1. Home
  2. FHI vs NVST Comparison

FHI vs NVST Comparison

Compare FHI & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FHI
  • NVST
  • Stock Information
  • Founded
  • FHI 1955
  • NVST 2018
  • Country
  • FHI United States
  • NVST United States
  • Employees
  • FHI N/A
  • NVST N/A
  • Industry
  • FHI Investment Managers
  • NVST Medical/Dental Instruments
  • Sector
  • FHI Finance
  • NVST Health Care
  • Exchange
  • FHI Nasdaq
  • NVST Nasdaq
  • Market Cap
  • FHI 4.0B
  • NVST 3.4B
  • IPO Year
  • FHI N/A
  • NVST 2019
  • Fundamental
  • Price
  • FHI $53.39
  • NVST $20.41
  • Analyst Decision
  • FHI Buy
  • NVST Buy
  • Analyst Count
  • FHI 7
  • NVST 12
  • Target Price
  • FHI $47.86
  • NVST $20.91
  • AVG Volume (30 Days)
  • FHI 653.5K
  • NVST 2.0M
  • Earning Date
  • FHI 10-30-2025
  • NVST 10-30-2025
  • Dividend Yield
  • FHI 2.57%
  • NVST N/A
  • EPS Growth
  • FHI 53.50
  • NVST N/A
  • EPS
  • FHI 4.52
  • NVST 0.31
  • Revenue
  • FHI $1,681,523,000.00
  • NVST $2,552,900,000.00
  • Revenue This Year
  • FHI $7.41
  • NVST $6.55
  • Revenue Next Year
  • FHI $4.73
  • NVST $3.33
  • P/E Ratio
  • FHI $11.70
  • NVST $65.47
  • Revenue Growth
  • FHI 5.55
  • NVST 0.76
  • 52 Week Low
  • FHI $35.05
  • NVST $14.22
  • 52 Week High
  • FHI $54.42
  • NVST $23.00
  • Technical
  • Relative Strength Index (RSI)
  • FHI 58.17
  • NVST 45.87
  • Support Level
  • FHI $51.22
  • NVST $20.28
  • Resistance Level
  • FHI $53.09
  • NVST $21.24
  • Average True Range (ATR)
  • FHI 0.75
  • NVST 0.50
  • MACD
  • FHI -0.00
  • NVST -0.03
  • Stochastic Oscillator
  • FHI 91.99
  • NVST 37.17

About FHI Federated Hermes Inc.

Federated Hermes provides asset-management services for institutional and individual investors. The firm had $843.7 billion in managed assets at the end of June 2025, composed of equity (10%), multi-asset (less than 1%), fixed-income (12%), alternative (2%), and money market (75%) funds. The firm's cash-management operations are expected to generate around 52% of Federated's revenue this year, compared with 29%, 11%, and 8%, respectively, for the equity, fixed-income, and alternatives/multi-asset/other operations. The company's products are distributed via trust banks, wealth managers, and retail broker/dealers (67% of AUM), institutional investors (26%), and international clients (7%).

About NVST Envista Holdings Corporation

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.

Share on Social Networks: